Imeik Technology Development Co (300896)

Currency in CNY
94.27
+1.73(+1.87%)
Closed·
300896 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
91.7095.33
52 wk Range
90.50202.88
Key Statistics
Bid/Ask
93.99 / 94.27
Prev. Close
92.54
Open
92.13
Day's Range
91.7-95.33
52 wk Range
90.5-202.88
Volume
3.74M
Average Volume (3m)
2.8M
1-Year Change
-48.1748%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300896 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
147.32
Upside
+56.28%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Analyst Ratings

9 Buy
3 Hold
1 Sell
Ratings:
13 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 147.32
(+56.28% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Nomura/Instinet
Hold123.90+31.43%-New CoverageApr 01, 2026
Huatai Financial
Buy155.04+64.46%182.16MaintainMar 26, 2026
Citi
Buy152.00+61.24%200.00MaintainMar 25, 2026
Macquarie
Buy162.60+72.48%181.00MaintainMar 20, 2026
Macquarie
Buy181.00+92.00%203.00MaintainOct 29, 2025

Earnings

Latest Release
Apr 23, 2026
EPS / Forecast
0.99 / 1.20
Revenue / Forecast
634M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.80%
Dividend Yield
2.16%
Industry Median 1.81%
Annualized payout
2.00
Paid annually
5-Years Growth
+7.57%
Growth Streak

300896 Income Statement

Compare 300896 to Peers and Sector

Metrics to compare
300896
Peers
Sector
Relationship
P/E Ratio
24.8x36.3x−0.5x
PEG Ratio
−0.640.470.00
Price/Book
3.6x2.4x2.6x
Price / LTM Sales
11.7x6.4x3.0x
Upside (Analyst Target)
58.1%50.0%58.6%
Fair Value Upside
Unlock22.5%10.2%Unlock

Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate composite solution for injection; modified sodium hyaluronate gel for injection; medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel; and skin care products. It serves medical aesthetic institutions. The company was incorporated in 2004 and is headquartered in Beijing, China.

Employees
1458
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
34.08M11.31%3.21B
Other Institutional Investors
47.00M15.59%4.43B
Public Companies & Retail Investors
220.35M73.10%20.77B
Total
301.43M100.00%28.42B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Hwabao CSI Medical ETF1.54%4,656,820438,998
E Fund ChiNext ETF1.14%3,425,445322,917

People Also Watch

34.10
300628
-1.16%
27.75
002128
-2.73%
25.96
002223
+2.53%
11.79
002507
+0.86%

FAQ

What Is the Imeik (300896) Stock Price Today?

The Imeik stock price today is 94.27 CNY.

What Stock Exchange Does Imeik Trade On?

Imeik is listed and trades on the Shenzhen Stock Exchange.

What Is the Stock Symbol for Imeik?

The stock symbol for Imeik is "300896."

Does Imeik Pay Dividends? What’s The Current Dividend Yield?

The Imeik dividend yield is 2.16%.

What Is the Imeik Market Cap?

As of today, Imeik market cap is 28.42B CNY.

What Is Imeik's Earnings Per Share (TTM)?

The Imeik EPS (TTM) is 3.80.

When Is the Next Imeik Earnings Date?

Imeik will release its next earnings report on Aug 25, 2026.

From a Technical Analysis Perspective, Is 300896 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Imeik Stock Split?

Imeik has split 2 times.

How Many Employees Does Imeik Have?

Imeik has 1458 employees.

What is the current trading status of Imeik (300896)?

As of Jun 13, 2026, Imeik (300896) is trading at a price of 94.27 CNY, with a previous close of 92.54 CNY. The stock has fluctuated within a day range of 91.70 CNY to 95.33 CNY, while its 52-week range spans from 90.50 CNY to 202.88 CNY.

What Is Imeik (300896) Price Target According to Analysts?

The average 12-month price target for Imeik is 147.32 CNY, with a high estimate of 188 CNY and a low estimate of 110 CNY. 9 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +56.28% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.